PDB Short entry for 1O8A HEADER METALLOPROTEASE 26-NOV-02 1O8A TITLE CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERTING ENZYME (NATIVE). CAVEAT 1O8A NAG A 695 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN CONVERTING ENZYME; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 68-656; COMPND 5 SYNONYM: ACE-T, DIPEPTIDYL CARBOXYPEPTIDASE I, KININASE II; COMPND 6 EC: 3.4.15.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: TESTIS; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS METALLOPROTEASE, ACE, PEPTIDYL DIPEPTIDASE, TYPE-I MEMBRANE-ANCHORED KEYWDS 2 PROTEIN. EXPDTA X-RAY DIFFRACTION AUTHOR R.NATESH,S.L.U.SCHWAGER,E.D.STURROCK,K.R.ACHARYA REVDAT 7 13-DEC-23 1O8A 1 HETSYN REVDAT 6 29-JUL-20 1O8A 1 COMPND REMARK HETNAM LINK REVDAT 6 2 1 SITE REVDAT 5 11-JUL-18 1O8A 1 CAVEAT COMPND JRNL HET REVDAT 5 2 1 HETNAM FORMUL LINK ATOM REVDAT 4 24-FEB-09 1O8A 1 VERSN REVDAT 3 06-MAR-06 1O8A 1 TITLE REMARK REVDAT 2 11-JUL-03 1O8A 1 JRNL REVDAT 1 07-FEB-03 1O8A 0 JRNL AUTH R.NATESH,S.L.SCHWAGER,E.D.STURROCK,K.R.ACHARYA JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN ANGIOTENSIN-CONVERTING JRNL TITL 2 ENZYME-LISINOPRIL COMPLEX. JRNL REF NATURE V. 421 551 2003 JRNL REFN ISSN 0028-0836 JRNL PMID 12540854 JRNL DOI 10.1038/NATURE01370 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.1 REMARK 3 NUMBER OF REFLECTIONS : 41402 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1675 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4660 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 100 REMARK 3 SOLVENT ATOMS : 504 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.220 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.35 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1O8A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-NOV-02. REMARK 100 THE DEPOSITION ID IS D_1290011783. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.70 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.488 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 42782 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.4600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.43200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.440 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1O86 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000/SODIUM ACETATE., PH 4.70 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.31000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 66.89500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.53000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.89500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.31000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.53000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 CONVERTS ANGIOTENSIN I TO ANGIOTENSIN II BY RELEASE OF REMARK 400 THE TERMINAL HIS-LEU, THIS RESULTS IN AN INCREASE OF THE REMARK 400 VASOCONSTRICTOR ACTIVITY OF ANGIOTENSIN. ALSO ABLE TO INACTIVATE REMARK 400 BRADYKININ, A POTENT VASODILATOR AND ACTS ON VARIOUS OTHER REMARK 400 OLIGOPEPTIDES WITH FREE C-TERMINUS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 37 REMARK 465 VAL A 38 REMARK 465 THR A 39 REMARK 465 SER A 435 REMARK 465 GLU A 436 REMARK 465 GLY A 437 REMARK 465 GLY A 438 REMARK 465 TYR A 619 REMARK 465 ASN A 620 REMARK 465 TRP A 621 REMARK 465 THR A 622 REMARK 465 PRO A 623 REMARK 465 ASN A 624 REMARK 465 SER A 625 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 40 CG OD1 OD2 REMARK 470 GLU A 64 CG CD OE1 OE2 REMARK 470 LYS A 117 CG CD CE NZ REMARK 470 SER A 298 OG REMARK 470 GLU A 303 CG CD OE1 OE2 REMARK 470 LYS A 307 CG CD CE NZ REMARK 470 SER A 439 CB OG REMARK 470 ASP A 440 CG OD1 OD2 REMARK 470 GLN A 618 CA C O CB CG CD OE1 REMARK 470 GLN A 618 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 72 76.67 -169.41 REMARK 500 GLU A 123 -136.53 49.77 REMARK 500 GLN A 308 33.14 -97.76 REMARK 500 ASP A 346 -6.67 -53.05 REMARK 500 LYS A 363 -39.81 -133.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 701 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 383 NE2 REMARK 620 2 HIS A 387 NE2 106.6 REMARK 620 3 GLU A 411 OE1 95.6 105.0 REMARK 620 4 ACT A 700 OXT 101.8 89.5 153.1 REMARK 620 5 ACT A 700 O 118.9 127.5 95.5 58.2 REMARK 620 N 1 2 3 4 REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1O86 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX REMARK 900 WITH LISINOPRIL. DBREF 1O8A A 37 625 UNP P22966 ACET_HUMAN 68 656 SEQRES 1 A 589 LEU VAL THR ASP GLU ALA GLU ALA SER LYS PHE VAL GLU SEQRES 2 A 589 GLU TYR ASP ARG THR SER GLN VAL VAL TRP ASN GLU TYR SEQRES 3 A 589 ALA GLU ALA ASN TRP ASN TYR ASN THR ASN ILE THR THR SEQRES 4 A 589 GLU THR SER LYS ILE LEU LEU GLN LYS ASN MET GLN ILE SEQRES 5 A 589 ALA ASN HIS THR LEU LYS TYR GLY THR GLN ALA ARG LYS SEQRES 6 A 589 PHE ASP VAL ASN GLN LEU GLN ASN THR THR ILE LYS ARG SEQRES 7 A 589 ILE ILE LYS LYS VAL GLN ASP LEU GLU ARG ALA ALA LEU SEQRES 8 A 589 PRO ALA GLN GLU LEU GLU GLU TYR ASN LYS ILE LEU LEU SEQRES 9 A 589 ASP MET GLU THR THR TYR SER VAL ALA THR VAL CYS HIS SEQRES 10 A 589 PRO ASN GLY SER CYS LEU GLN LEU GLU PRO ASP LEU THR SEQRES 11 A 589 ASN VAL MET ALA THR SER ARG LYS TYR GLU ASP LEU LEU SEQRES 12 A 589 TRP ALA TRP GLU GLY TRP ARG ASP LYS ALA GLY ARG ALA SEQRES 13 A 589 ILE LEU GLN PHE TYR PRO LYS TYR VAL GLU LEU ILE ASN SEQRES 14 A 589 GLN ALA ALA ARG LEU ASN GLY TYR VAL ASP ALA GLY ASP SEQRES 15 A 589 SER TRP ARG SER MET TYR GLU THR PRO SER LEU GLU GLN SEQRES 16 A 589 ASP LEU GLU ARG LEU PHE GLN GLU LEU GLN PRO LEU TYR SEQRES 17 A 589 LEU ASN LEU HIS ALA TYR VAL ARG ARG ALA LEU HIS ARG SEQRES 18 A 589 HIS TYR GLY ALA GLN HIS ILE ASN LEU GLU GLY PRO ILE SEQRES 19 A 589 PRO ALA HIS LEU LEU GLY ASN MET TRP ALA GLN THR TRP SEQRES 20 A 589 SER ASN ILE TYR ASP LEU VAL VAL PRO PHE PRO SER ALA SEQRES 21 A 589 PRO SER MET ASP THR THR GLU ALA MET LEU LYS GLN GLY SEQRES 22 A 589 TRP THR PRO ARG ARG MET PHE LYS GLU ALA ASP ASP PHE SEQRES 23 A 589 PHE THR SER LEU GLY LEU LEU PRO VAL PRO PRO GLU PHE SEQRES 24 A 589 TRP ASN LYS SER MET LEU GLU LYS PRO THR ASP GLY ARG SEQRES 25 A 589 GLU VAL VAL CYS HIS ALA SER ALA TRP ASP PHE TYR ASN SEQRES 26 A 589 GLY LYS ASP PHE ARG ILE LYS GLN CYS THR THR VAL ASN SEQRES 27 A 589 LEU GLU ASP LEU VAL VAL ALA HIS HIS GLU MET GLY HIS SEQRES 28 A 589 ILE GLN TYR PHE MET GLN TYR LYS ASP LEU PRO VAL ALA SEQRES 29 A 589 LEU ARG GLU GLY ALA ASN PRO GLY PHE HIS GLU ALA ILE SEQRES 30 A 589 GLY ASP VAL LEU ALA LEU SER VAL SER THR PRO LYS HIS SEQRES 31 A 589 LEU HIS SER LEU ASN LEU LEU SER SER GLU GLY GLY SER SEQRES 32 A 589 ASP GLU HIS ASP ILE ASN PHE LEU MET LYS MET ALA LEU SEQRES 33 A 589 ASP LYS ILE ALA PHE ILE PRO PHE SER TYR LEU VAL ASP SEQRES 34 A 589 GLN TRP ARG TRP ARG VAL PHE ASP GLY SER ILE THR LYS SEQRES 35 A 589 GLU ASN TYR ASN GLN GLU TRP TRP SER LEU ARG LEU LYS SEQRES 36 A 589 TYR GLN GLY LEU CYS PRO PRO VAL PRO ARG THR GLN GLY SEQRES 37 A 589 ASP PHE ASP PRO GLY ALA LYS PHE HIS ILE PRO SER SER SEQRES 38 A 589 VAL PRO TYR ILE ARG TYR PHE VAL SER PHE ILE ILE GLN SEQRES 39 A 589 PHE GLN PHE HIS GLU ALA LEU CYS GLN ALA ALA GLY HIS SEQRES 40 A 589 THR GLY PRO LEU HIS LYS CYS ASP ILE TYR GLN SER LYS SEQRES 41 A 589 GLU ALA GLY GLN ARG LEU ALA THR ALA MET LYS LEU GLY SEQRES 42 A 589 PHE SER ARG PRO TRP PRO GLU ALA MET GLN LEU ILE THR SEQRES 43 A 589 GLY GLN PRO ASN MET SER ALA SER ALA MET LEU SER TYR SEQRES 44 A 589 PHE LYS PRO LEU LEU ASP TRP LEU ARG THR GLU ASN GLU SEQRES 45 A 589 LEU HIS GLY GLU LYS LEU GLY TRP PRO GLN TYR ASN TRP SEQRES 46 A 589 THR PRO ASN SER MODRES 1O8A ASN A 72 ASN GLYCOSYLATION SITE MODRES 1O8A ASN A 90 ASN GLYCOSYLATION SITE MODRES 1O8A ASN A 109 ASN GLYCOSYLATION SITE MODRES 1O8A ASN A 155 ASN GLYCOSYLATION SITE MODRES 1O8A ASN A 337 ASN GLYCOSYLATION SITE MODRES 1O8A ASN A 586 ASN GLYCOSYLATION SITE HET NAG A 691 14 HET NAG A 692 14 HET NAG A 693 14 HET NAG A 694 14 HET NAG A 695 14 HET NAG A 696 14 HET ACT A 700 4 HET ZN A 701 1 HET NXA A 702 9 HET CL A 703 1 HET CL A 704 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ACT ACETATE ION HETNAM ZN ZINC ION HETNAM NXA N-CARBOXYALANINE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 6(C8 H15 N O6) FORMUL 8 ACT C2 H3 O2 1- FORMUL 9 ZN ZN 2+ FORMUL 10 NXA C4 H7 N O4 FORMUL 11 CL 2(CL 1-) FORMUL 13 HOH *504(H2 O) HELIX 1 1 ASP A 40 THR A 71 1 32 HELIX 2 2 THR A 74 ARG A 100 1 27 HELIX 3 3 LYS A 101 LEU A 107 5 7 HELIX 4 4 ASN A 109 GLN A 120 1 12 HELIX 5 5 LEU A 122 LEU A 127 5 6 HELIX 6 6 PRO A 128 VAL A 148 1 21 HELIX 7 7 PRO A 163 SER A 172 1 10 HELIX 8 8 LYS A 174 LEU A 210 1 37 HELIX 9 9 ASP A 215 SER A 222 1 8 HELIX 10 10 MET A 223 GLU A 225 5 3 HELIX 11 11 SER A 228 GLY A 260 1 33 HELIX 12 12 TRP A 283 ASN A 285 5 3 HELIX 13 13 ILE A 286 VAL A 291 1 6 HELIX 14 14 ASP A 300 GLN A 308 1 9 HELIX 15 15 THR A 311 LEU A 326 1 16 HELIX 16 16 PRO A 332 SER A 339 1 8 HELIX 17 17 ASN A 374 TYR A 394 1 21 HELIX 18 18 PRO A 398 ARG A 402 5 5 HELIX 19 19 ASN A 406 LEU A 430 1 25 HELIX 20 20 SER A 439 ASP A 473 1 35 HELIX 21 21 ASN A 480 GLY A 494 1 15 HELIX 22 22 PHE A 506 LYS A 511 5 6 HELIX 23 23 TYR A 520 ALA A 541 1 22 HELIX 24 24 PRO A 546 CYS A 550 5 5 HELIX 25 25 SER A 555 LEU A 568 1 14 HELIX 26 26 PRO A 573 GLY A 583 1 11 HELIX 27 27 ALA A 589 HIS A 610 1 22 SHEET 1 AA 2 ALA A 149 HIS A 153 0 SHEET 2 AA 2 SER A 157 LEU A 161 -1 O LEU A 159 N VAL A 151 SHEET 1 AB 2 ILE A 270 ALA A 272 0 SHEET 2 AB 2 LEU A 495 CYS A 496 1 N CYS A 496 O ILE A 270 SHEET 1 AC 2 SER A 355 PHE A 359 0 SHEET 2 AC 2 ASP A 364 LYS A 368 -1 O ARG A 366 N TRP A 357 SSBOND 1 CYS A 152 CYS A 158 1555 1555 2.03 SSBOND 2 CYS A 352 CYS A 370 1555 1555 2.03 SSBOND 3 CYS A 538 CYS A 550 1555 1555 2.03 LINK ND2 ASN A 72 C1 NAG A 691 1555 1555 1.46 LINK ND2 ASN A 72 O5 NAG A 691 1555 1555 1.88 LINK ND2 ASN A 90 C1 NAG A 692 1555 1555 1.45 LINK ND2 ASN A 109 C1 NAG A 693 1555 1555 1.45 LINK ND2 ASN A 155 C1 NAG A 694 1555 1555 1.45 LINK ND2 ASN A 337 C1 NAG A 695 1555 1555 1.46 LINK ND2 ASN A 586 C1 NAG A 696 1555 1555 1.46 LINK NE2 HIS A 383 ZN ZN A 701 1555 1555 2.02 LINK NE2 HIS A 387 ZN ZN A 701 1555 1555 2.06 LINK OE1 GLU A 411 ZN ZN A 701 1555 1555 1.97 LINK OXT ACT A 700 ZN ZN A 701 1555 1555 2.60 LINK O ACT A 700 ZN ZN A 701 1555 1555 2.06 CISPEP 1 GLU A 162 PRO A 163 0 0.16 CRYST1 56.620 85.060 133.790 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017662 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011756 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007474 0.00000